BA vs XERS · P/E 89, rev $24.56B vs rev $175.2M
The Boeing Company (BA) versus Xeris Pharmaceuticals Inc (XERS) — a side-by-side from cached financials, not a winner call.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
Latest reported BA revenue for 2026-06-30 was $24.56B. Net income was -$444.0M. Revenue was up 10.5% from 2026-03-31 to 2026-06-30. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Latest reported XERS revenue for 2026-06-30 was $175.2M. Net income was -$28.9M. XERS currently screens at market cap $760.7M.
BA currently screens at market cap $177.86B and trailing P/E 89.2. XERS currently screens at market cap $760.7M.
Not investment advice. Open the BA and XERS stock pages for the full models.
Not investment advice.